Survival improvement in thalassemia: who should take the credit?
Piga
Antonio
A
Department of Pediatric Hematology, Università di Torino, Italy. antonio.piga@unito.it
D004359:Drug Therapy, Combination; D006801:Humans; D007502:Iron Chelating Agents / Q000627:therapeutic use; D015996:Survival Rate; D013789:Thalassemia / Q000188:drug therapy* / Q000453:epidemiology* / Q000401:mortality
D007502:Iron Chelating Agents